PL188041B1 - Linia komórkowa T pochodzenia kociego - Google Patents

Linia komórkowa T pochodzenia kociego

Info

Publication number
PL188041B1
PL188041B1 PL35824896A PL35824896A PL188041B1 PL 188041 B1 PL188041 B1 PL 188041B1 PL 35824896 A PL35824896 A PL 35824896A PL 35824896 A PL35824896 A PL 35824896A PL 188041 B1 PL188041 B1 PL 188041B1
Authority
PL
Poland
Prior art keywords
fiv
cell line
infected
fet
cells
Prior art date
Application number
PL35824896A
Other languages
English (en)
Polish (pl)
Inventor
Janet K. Yamamoto
Original Assignee
Univ California
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Univ Florida filed Critical Univ California
Publication of PL188041B1 publication Critical patent/PL188041B1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/21Retroviridae, e.g. equine infectious anemia virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • C07K16/1045Lentiviridae, e.g. HIV, FIV, SIV
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5156Animal cells expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
PL35824896A 1995-08-25 1996-08-23 Linia komórkowa T pochodzenia kociego PL188041B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51938695A 1995-08-25 1995-08-25
PCT/US1996/013580 WO1997007817A1 (en) 1995-08-25 1996-08-23 Multi-subtype fiv vaccines

Publications (1)

Publication Number Publication Date
PL188041B1 true PL188041B1 (pl) 2004-11-30

Family

ID=24068097

Family Applications (2)

Application Number Title Priority Date Filing Date
PL35824896A PL188041B1 (pl) 1995-08-25 1996-08-23 Linia komórkowa T pochodzenia kociego
PL96325376A PL186706B1 (pl) 1995-08-25 1996-08-23 Szczepionki przeciw wielu podtypom FIV

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL96325376A PL186706B1 (pl) 1995-08-25 1996-08-23 Szczepionki przeciw wielu podtypom FIV

Country Status (17)

Country Link
US (5) US5846825A (ja)
EP (2) EP1090985B1 (ja)
JP (4) JP4142741B2 (ja)
KR (2) KR100502568B1 (ja)
AT (2) ATE335809T1 (ja)
AU (3) AU728750B2 (ja)
BR (1) BR9610343A (ja)
CA (1) CA2230029C (ja)
DE (3) DE69636440D1 (ja)
DK (2) DK0848615T3 (ja)
ES (2) ES2269042T3 (ja)
HK (1) HK1038584A1 (ja)
IL (3) IL163873A0 (ja)
NZ (3) NZ502144A (ja)
PL (2) PL188041B1 (ja)
PT (2) PT848615E (ja)
WO (1) WO1997007817A1 (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9610343A (pt) 1995-08-25 1999-12-21 Univ Florida Vacinas de subtipos múltiplos para fiv
US6254872B1 (en) * 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
US6458528B1 (en) * 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
AU2002244103A1 (en) 2001-02-22 2002-09-12 University Of Florida Materials and methods for detecting, preventing, and treating hiv and fiv retroviral infection
DK1385540T3 (da) 2001-05-10 2011-10-24 Wyeth Llc Sammensætning og fremgangsmåde til forhøjelse af celledensitet i cellekulturer, der er inficeret med lentivirus
JP2006528244A (ja) 2003-05-12 2006-12-14 ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド Fiv感染予防接種のための材料と方法
US7658927B2 (en) * 2003-05-12 2010-02-09 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against FIV infection
AU2004273076B2 (en) * 2003-09-11 2008-02-14 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4717009B2 (ja) 2003-12-18 2011-07-06 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法と装置
AU2005215629B2 (en) 2004-02-19 2009-01-29 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4662988B2 (ja) * 2004-06-30 2011-03-30 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスを検出するための方法および装置
US7285278B2 (en) 2004-06-30 2007-10-23 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2006011920A1 (en) 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US8394581B2 (en) 2007-07-25 2013-03-12 The Kitasato Institute Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test
US8809004B2 (en) 2010-04-02 2014-08-19 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus
US8596026B2 (en) * 2010-08-05 2013-12-03 Kraft Foods Group Brands Llc Vacuum flow wrap packaging system and method of packaging

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341439C (en) * 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
US6107077A (en) 1987-08-26 2000-08-22 Yamamoto; Janet K. Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines
US5118602A (en) 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
WO1992000098A1 (en) * 1990-06-29 1992-01-09 Daniel Zagury Methods of inducing immune response to aids virus
AU2299892A (en) * 1991-07-05 1993-02-11 Regents Of The University Of California, The Feline lymphoid cell lines capable of producing fiv
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
WO1994020622A1 (en) * 1993-03-11 1994-09-15 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
IT1276509B1 (it) * 1995-03-31 1997-10-31 Istituto Superiore Della Sanit Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
US6254872B1 (en) 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
BR9610343A (pt) 1995-08-25 1999-12-21 Univ Florida Vacinas de subtipos múltiplos para fiv

Also Published As

Publication number Publication date
KR19990044093A (ko) 1999-06-25
JP5339687B2 (ja) 2013-11-13
IL163873A0 (en) 2005-12-18
HK1038584A1 (en) 2002-03-22
EP0848615B1 (en) 2005-06-08
NZ513388A (en) 2006-02-24
JPH11513031A (ja) 1999-11-09
IL123264A (en) 2006-09-05
AU728750B2 (en) 2001-01-18
US20040067242A1 (en) 2004-04-08
US5846825A (en) 1998-12-08
AU772353B2 (en) 2004-04-22
PL325376A1 (en) 1998-07-20
DE69634820T2 (de) 2006-03-23
DE69636440T4 (de) 2007-09-27
JP2005261426A (ja) 2005-09-29
DE69636440T2 (de) 2006-12-21
KR20040047812A (ko) 2004-06-05
EP0848615A1 (en) 1998-06-24
NZ316347A (en) 2000-02-28
US6447993B1 (en) 2002-09-10
JP4142741B2 (ja) 2008-09-03
DK1090985T3 (da) 2006-12-04
WO1997007817A1 (en) 1997-03-06
AU2004203358B2 (en) 2007-10-25
CA2230029A1 (en) 1997-03-06
AU2004203358A1 (en) 2004-08-19
ATE335809T1 (de) 2006-09-15
JP2007284442A (ja) 2007-11-01
US6605282B2 (en) 2003-08-12
IL123264A0 (en) 1998-09-24
JP2013079286A (ja) 2013-05-02
DE69634820D1 (de) 2005-07-14
BR9610343A (pt) 1999-12-21
ES2269042T3 (es) 2007-04-01
PT1090985E (pt) 2006-12-29
PT848615E (pt) 2005-10-31
US7311921B2 (en) 2007-12-25
KR100482616B1 (ko) 2005-09-02
EP1090985B1 (en) 2006-08-09
ATE297218T1 (de) 2005-06-15
US20080145381A1 (en) 2008-06-19
DK0848615T3 (da) 2005-10-03
KR100502568B1 (ko) 2005-07-20
AU6855596A (en) 1997-03-19
US20020172941A1 (en) 2002-11-21
PL186706B1 (pl) 2004-02-27
EP1090985A1 (en) 2001-04-11
ES2242967T3 (es) 2005-11-16
CA2230029C (en) 2012-03-27
JP4413132B2 (ja) 2010-02-10
DE69636440D1 (de) 2006-09-21
AU1972501A (en) 2001-05-03
NZ502144A (en) 2001-09-28

Similar Documents

Publication Publication Date Title
JP5339687B2 (ja) 多種サブタイプfivワクチン
US20090263417A1 (en) Multi-subtype FIV vaccines
CARLSON et al. Vaccine protection of rhesus macaques against simian immunodeficiency virus infection
CA2525641A1 (en) Materials and methods for immunizing against fiv infection
AU682304B2 (en) Analogous peptides of the internal image of a viral protein
JPS63502242A (ja) エイズの原因となる新規なレトロウイルス及び該レトロウイルスのin vitro検出手段及び方法
MXPA98001570A (en) Feline immunodeficiency vaccines of subtipos multip
YAMAMOTO Patent 2230029 Summary
Kariya et al. Protection of rabbits against HTLV-II infection with a synthetic peptide corresponding to HTLV-II neutralization region
PT86752B (pt) Processo para a preparacao de peptidos susceptiveis de serem reconhecidos por anticorpos induzidos contra retrovirus da imunodeficiencia humana (virus hiv) suas aplicacoes no diagnotico de infeccoes provocadas por alguns destes virus e em tal circunstancia a vacinacao contra a sida

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20140823